Vivek Ramaswamy

Vivek Ramaswamy

Formal First Name
1985 - present

Vivek Ramaswamy is a New York Times bestselling author, conservative political activist, and business leader leader who has founded multiple successful enterprises. Vivek is the Co-founder and Executive Chairman of Strive, an asset management firm focusing on excellence over politics. He is also a board member of Philanthropy Roundtable and The Foundation for Research on Equal Opportunity. Prior to Strive, he was the founder and CEO of Roivant business leader s, a biopharma company focused on the application of technology to drug development. He founded Roivant in 2014 and led the largest biotech IPOs of 2015 and 2016, eventually leading in successful clinical trials in multiple disease areas that led to FDA-approved products. In 2020, he emerged as a prominent national commentator on stakeholder capitalism, free speech, and woke culture. The author of "Woke, Inc." and "Nation of Victims," he was labeled "one of the intellectual godfathers of the anti-woke movement" by Politico. In February 2023, he announced his candidacy in the 2024 Republican Party presidential primaries.

Professional Experience

Academic History


  • He was behind the biggest biotechnology initial public offering of 2016, Myovant Sciences, which raised $218 million listing its shares on Nasdaq.

  • He pulled off the biggest IPO in U.S. biotech history by listing shares of Axovant, a company that is trying to develop a new Alzheimer's drug.


  • 2016 Forbes America's Richest Entrepreneurs Under 40

  • 2014 Forbes 30 Under 30 Finance

  • He was featured on the cover of Forbes magazine in 2015 for his work in drug development.